The primary objective of this study is to determine the ex-vivo prognostic accuracy of the Cybrid live tumor diagnostic platform across a basket of solid tumors, using in-vivo RECIST 1.1 as the reference method.
The primary objective of this study is to determine the ex-vivo prognostic accuracy of the Cybrid live tumor diagnostic platform across a basket of solid tumors, using in-vivo RECIST 1.1 as the reference method.
Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform
-
Salinas Valley Memorial Healthcare System, Salinas, California, United States, 93901
AdventHealth Orlando, Orlando, Florida, United States, 32803
Cleveland Clinic Florida, Stuart, Florida, United States, 34994
University of South Florida (Tampa General Hospital), Tampa, Florida, United States, 33606
University of Louisville James Graham Brown Cancer Center, Louisville, Kentucky, United States, 40202
Meritus Health, Hagerstown, Maryland, United States, 21742
John Theurer Cancer Center, Hackensack, New Jersey, United States, 07601
Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States, 14203
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States, 27599
University of Wisconsin, Madison, Wisconsin, United States, 53705
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Elephas,
Fred Hausheer, MD, FACP, STUDY_DIRECTOR, Elephas
2027-01